Table.
Optimal testing and isolation strategies and price thresholds for cost-effective testing for each potential Re for SARS-CoV-2 transmission
|
Optimal strategy (assuming $5 per test) |
Testing threshold (cost per test) | |||
|---|---|---|---|---|
| Testing frequency (days between tests)* | Isolation period | Probability of error | ||
| 1·1 | 28 | 1 week | 0·65 | $75 |
| 1·2 | 28 | 1 week | 0·66 | $125 |
| 1·3 | 14 | 1 week | 0·69 | $175 |
| 1·4 | 14 | 1 week | 0·65 | $350 |
| 1·5 | 7 | 1 week | 0·72 | $325 |
| 1·6 | 7 | 1 week | 0·63 | $375 |
| 1·7 | 7 | 1 week | 0·62 | $425 |
| 1·8 | 7 | 1 week | 0·62 | $475 |
| 1·9 | 7 | 2 weeks | 0·45 | $450 |
| 2·0 | 7 | 2 weeks | 0·40 | $375 |
| 2·1 | 7 | 2 weeks | 0·40 | $350 |
| 2·2 | 7 | 2 weeks | 0·43 | $400 |
| 2·5 | 1 | 2 weeks | 0·43 | $400 |
| 3 | 1 | 2 weeks | 0·18 | $275 |
The middle columns give the optimal testing and isolation strategies and probability of error for each Re scenario, assuming that each test costs US$5 and assuming a societal willingness to pay per YLL averted of $100 000. The rightmost column gives a threshold price above which the status-quo strategy (ie, symptom-based testing and isolation) is expected to be more cost-effective than all eight testing strategies considered. The threshold value was identified by assessing all strategies across a range of costs per test up to $2000 at $25 increments. The low transmission and high transmission scenarios in Figure 2, Figure 3 correspond to Re of 1·2 for low transmission and 2·2 for high transmission. Re=effective reproduction number. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. YLLs=years of life lost.
A 7-day testing frequency means that individuals are tested once every 7 days, on a rotating basis.